MACKANESS JAMES H (Chief Financial Officer) sold 9.6% of their position (14.98K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $683.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 8/7/2024ACC: 0001415889-24-020945
Officer· Chief Financial Officer
Since Nov 2019
-14.98K
Net shares
Net seller
$683.2K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
14.98K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−3.86K
Price / share
$45.48
Trade value
$175.45K
% of position
2.5%
8/5/2024
155.76K→151.91K
Common Stock
Direct
Shares
−2.99K
Price / share
$46.14
Trade value
$138.02K
% of position
2.0%
8/5/2024
151.91K→148.91K
Common Stock
Direct
Shares
−799.00
Price / share
$43.64
Trade value
$34.87K
% of position
0.5%
8/6/2024
148.91K→148.12K
Common Stock
Direct
Shares
−2.70K
Price / share
$45.25
Trade value
$122.12K
% of position
1.8%
8/6/2024
148.12K→145.42K
Common Stock
Direct
Shares
−4.64K
Price / share
$45.89
Trade value
$212.75K
% of position
3.2%
8/6/2024
145.42K→140.78K
Total
Net shares
−14.98K
Net value
-$683.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/5/2024 | S · Sale | −3.86K | $45.48 | $175.45K | 2.5% | 155.76K | 151.91K |
| Common Stock Direct | 8/5/2024 | S · Sale | −2.99K | $46.14 | $138.02K | 2.0% | 151.91K | 148.91K |
| Common Stock Direct | 8/6/2024 | S · Sale | −799.00 | $43.64 | $34.87K | 0.5% | 148.91K | 148.12K |
| Common Stock Direct | 8/6/2024 | S · Sale | −2.70K | $45.25 | $122.12K | 1.8% | 148.12K | 145.42K |
| Common Stock Direct | 8/6/2024 | S · Sale | −4.64K | $45.89 | $212.75K | 3.2% | 145.42K | 140.78K |
| Total | −14.98K | -$683.20K | ||||||
Derivative Transactions0
No derivative transactions reported